Amyloid Core Formed of Full-Length Recombinant Mouse Prion Protein Involves Sequence 127-143 but Not Sequence 107-126

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Chatterjee, Biswanath ^a   Lee, Chung Yu ^a,b   Lin, Chen ^a   Chen, Eric H L ^a   Huang, Chao Li ^b   Yang, Chien Chih ^b   Chen, Rita P Y ^a,b  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN; PRION PROTEIN [107-126]; PRION PROTEIN [107-143]; PRION PROTEIN [127-143]; UNCLASSIFIED DRUG;

ARTICLE; BETA SHEET; CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; AMYLOID; ANIMALS; KINETICS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PRIONS; PROTEIN FOLDING; RECOMBINANT PROTEINS;

EID: 84879748161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067967     Document Type: Article

References (50)

1. Prusiner SB, (1998) Prions. Proc Natl Acad Sci USA 95: 13363-13383.
2. Aguzzi A, Polymenidou M, (2004) Mammalian prion biology: one century of evolving concepts. Cell 116: 313-327.
3. Chesebro B, (2003) Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull 66: 1-20.
4. Collinge J, (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24: 519-550.
5. Cohen FE, Prusiner SB, (1998) Pathologic conformations of prion proteins. Annu Rev Biochem 67: 793-819.
6. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, et al. (1996) NMR structure of the mouse prion protein domain PrP(121-231). Nature 382: 180-182.
7. Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K, (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413: 282-288.
8. Riesner D, (2003) Biochemistry and structure of PrP(C) and PrP(Sc). Br Med Bull 66: 21-33.
9. Pan K, Baldwin M, Nguyen J, Gasset M, Serban A, et al. (1993) Conversion of α-helices β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90: 10962-10966.
10. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, et al. (1991) Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30: 7672-7680.
11. Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, et al. (1997) Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible. Proc Natl Acad Sci USA 94: 13452-13457.
12. Gasset M, Baldwin MA, Fletterick RJ, Prusiner SB, (1993) Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci USA 90: 1-5.
13. Safar J, Roller P, Gajdusek D, Gibbs C Jr, (1993) Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 268: 20276-20284.
14. McKinley MP, Bolton DC, Prusiner SB, (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35: 57-62.
15. Gasset M, Baldwin MA, Lloyd DH, Gabriel JM, Holtzman DM, et al. (1992) Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc Natl Acad Sci U S A 89: 10940-10944.
16. Baskakov IV, Aagaard C, Mehlhorn I, Wille H, Groth D, et al. (2000) Self-assembly of recombinant prion protein of 106 residues. Biochemistry 39: 2792-2804.
17. Walsh P, Simonetti K, Sharpe S, (2009) Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein. Structure 17: 417-426.
18. Lin NS, Chao JC, Cheng HM, Chou FC, Chang CF, et al. (2010) Molecular structure of amyloid fibrils formed by residues 127 to 147 of the human prion protein. Chemistry 16: 5492-5499.
19. Tagliavini F, Prelli F, Verga L, Giaccone G, Sarma R, et al. (1993) Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 90: 9678-9682.
20. Zhang H, Kaneko K, Nguyen JT, Livshits TL, Baldwin MA, et al. (1995) Conformational transitions in peptides containing two putative α-helices of the prion protein. J Mol Biol 250: 514-526.
21. Yamaguchi K, Matsumoto T, Kuwata K, (2008) Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide. Biochemistry 47: 13242-13251.
22. Ettaiche M, Pichot R, Vincent JP, Chabry J, (2000) In vivo cytotoxicity of the prion protein fragment 106-126. J Biol Chem 275: 36487-36490.
23. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, et al. (1993) Neurotoxicity of a prion protein fragment. Nature 362: 543-546.
24. Thellung S, Florio T, Corsaro A, Arena S, Merlino M, et al. (2000) Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106-126. Int J Dev Neurosci 18: 481-492.
25. Dupiereux I, Zorzi W, Lins L, Brasseur R, Colson P, et al. (2005) Interaction of the 106-126 prion peptide with lipid membranes and potential implication for neurotoxicity. Biochem Biophys Res Commun 331: 894-901.
26. Lin MC, Mirzabekov T, Kagan BL, (1997) Channel formation by a neurotoxic prion protein fragment. J Biol Chem 272: 44-47.
27. Kourie JI, Culverson A, (2000) Prion peptide fragment PrP[106-126] forms distinct cation channel types. J Neurosci Res 62: 120-133.
28. Haire LF, Whyte SM, Vasisht N, Gill AC, Verma C, et al. (2004) The crystal structure of the globular domain of sheep prion protein. J Mol Biol 336: 1175-1183.
29. DeMarco ML, Daggett V, (2004) From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci USA 101: 2293-2298.
30. DeMarco ML, Silveira J, Caughey B, Daggett V, (2006) Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. Biochemistry 45: 15573-15582.
31. Supattapone S, Bouzamondo E, Ball HL, Wille H, Nguyen HO, et al. (2001) A protease-resistant 61-residue prion peptide causes neurodegeneration in transgenic mice. Mol Cell Biol 21: 2608-2616.
32. Hsu RL, Lee KT, Wang JH, Lee LY, Chen RP, (2009) Amyloid-degrading ability of nattokinase from Bacillus subtilis natto. J Agri Food Chem 57: 503-508.
33. Makarava N, Baskakov IV, (2008) Expression and purification of full-length recombinant PrP of high purity. Methods Mol Biol 459: 131-143.
34. Lee LY, Chen RP, (2007) Quantifying the sequence-dependent species barrier between hamster and mouse prions. J Am Chem Soc 129: 1644-1652.
35. Alvarez-Martinez MT, Fontes P, Zomosa-Signoret V, Arnaud JD, Hingant E, et al. (2011) Dynamics of polymerization shed light on the mechanisms that lead to multiple amyloid structures of the prion protein. Biochim Biophys Acta 1814: 1305-1317.
36. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, et al. (1994) Cell-free formation of protease-resistant prion protein. Nature 370: 471-474.
37. Bocharova OV, Breydo L, Parfenov AS, Salnikov VV, Baskakov IV, (2005) In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrPSc. J Mol Biol 346: 645-659.
38. Lee SW, Mou Y, Lin SY, Chou FC, Tseng WH, et al. (2008) Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein. J Mol Biol 378: 1142-1154.
39. Liao TY, Lee LY, Chen RP, (2011) Leu-138 in the bovine prion peptide fibrils is involved in the seeding discrimination related to codon-129 M/V polymorphism in the prion peptide seeding experiment. FEBS J 278: 4351-4361.
40. Serpell LC, Sunde M, Blake CC, (1997) The molecular basis of amyloidosis. Cell Mol Life Sci 53: 871-887.
41. Blake C, Serpell L, (1996) Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure 4: 989-998.
42. Serpell LC, Blake CC, Fraser PE, (2000) Molecular structure of a fibrillar Alzheimer's A beta fragment. Biochemistry 39: 13269-13275.
43. Lopez De La Paz M, Goldie K, Zurdo J, Lacroix E, Dobson CM, et al. (2002) De novo designed peptide-based amyloid fibrils. Proc Natl Acad Sci USA 99: 16052-16057.
44. Garbuzynskiy SO, Lobanov MY, Galzitskaya OV, (2010) FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence. Bioinformatics 26: 326-332.
45. Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X, et al. (2007) AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8: 65-81.
46. Bocharova OV, Breydo L, Salnikov VV, Gill AC, Baskakov IV, (2005) Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease. Protein Sci 14: 1222-1232.
47. Kundu B, Maiti NR, Jones EM, Surewicz KA, Vanik DL, et al. (2003) Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Proc Natl Acad Sci USA 100: 12069-12074.
48. Chabry J, Caughey B, Chesebro B, (1998) Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J Biol Chem 273: 13203-13207.
49. Hafner-Bratkovic I, Bester R, Pristovsek P, Gaedtke L, Veranic P, et al. (2011) Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. J Biol Chem 286: 12149-12156.
50. Singh J, Sabareesan AT, Mathew MK, Udgaonkar JB, (2012) Development of the structural core and of conformational heterogeneity during the conversion of oligomers of the mouse prion protein to worm-like amyloid fibrils. J Mol Biol 423: 217-231.